Back to top

Livermore Lab Selects Fair Isaac's Software

Read MoreHide Full Article

Lawrence Livermore National Laboratory (LLNL) and Catholic University of Louvain, Belgium have recently partnered with Fair Isaac Corporation (FICO - Free Report) , a leading management software company, to incorporate the FICO Xpress Optimization Suite for large-scale renewable energy research work.

As a part of the research, LLNL needs to ascertain the lowest-cost scheduling of electric power grids. This involves the implementation of parallel optimization algorithms in order to determine variable factors to economically and efficiently meet the power requirement of a particular area. The research being carried out at LLNL involves working with variables on a very large scale in different weather conditions such as temperature, wind speed and cloud cover.

FICO software will also enable researchers to work on planning for various time scales. This software is competitive in comparison to other similar products available in the market and the complexities and challenges are likely to be resolved with the use of FICO Xpress software.

By building effective optimization solutions, the FICO Xpress Optimization Suite helps to work with high-performance algorithms in a flexible environment and rapid application and reporting capabilities for on-premise and cloud installations.

Fair Isaac helps businesses to make better decisions that drive higher levels of growth, profitability and customer satisfaction. The use of big data and mathematical algorithms to predict consumer behavior has transformed many industries. It provides analytics software and tools that are used across multiple industries to manage risk, fight fraud, optimize operations and meet strict government regulations.

Fair Isaac currently holds a Zacks Rank #2 (Buy). Other stocks in the industry that look promising include Acxiom Corporation (ACXM - Free Report) , Amdocs Limited (DOX - Free Report) and CDW Corporation  (CDW - Free Report) , all of which carry a Zacks Rank #2 (Buy).

More from Zacks Analyst Blog

You May Like